Unternehmen Goodbody Health Canadian Securities Exchange
Aktien
A3DCKF
CA3821591011
SWEL
Pharmazeutika
Kurzporträt
Umsatz nach Geschäftsbereich
USD in Millionen | 2020 | Gewichtung | 2021 | Gewichtung | Delta |
---|---|---|---|---|---|
Clinic Testing
92,6
%
| 1 | 20,5 % | 22 | 92,6 % | +4 049,80 % |
Cannaboid Products
3,8
%
| 2 | 64,5 % | 1 | 3,8 % | -45,40 % |
Wholesale
2,4
%
| 0 | 2,2 % | 1 | 2,4 % | +883,77 % |
Cannaboid Testing
1,2
%
| 0 | 12,8 % | 0 | 1,2 % | -16,19 % |
Umsatz je Region
USD in Millionen | 2020 | Gewichtung | 2021 | Gewichtung | Delta |
---|---|---|---|---|---|
United Kingdom
100,0
%
| 3 | 100,0 % | 23 | 100,0 % | +817,37 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
George Thomas
CEO | Chief Executive Officer | 35 | 26.01.21 |
Geremy Thomas
FOU | Founder | 64 | 14.02.11 |
John Pettit
CTO | Chief Tech/Sci/R&D Officer | - | - |
Emily Critchley
HRO | Human Resources Officer | - | - |
Paul van Issum
PRN | Corporate Officer/Principal | - | - |
Anne Tew
SEC | Corporate Secretary | - | 01.11.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Geremy Thomas
FOU | Founder | 64 | 14.02.11 |
George Thomas
CEO | Chief Executive Officer | 35 | 26.01.21 |
Anne Tew
SEC | Corporate Secretary | - | 01.11.18 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 364 962 760 | 256 430 105 ( 70,26 %) | 0 | 70,26 % |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Sativa Group Plc
Sativa Group Plc Financial ConglomeratesFinance Sativa Group Plc engages in the production, testing and compliance, commercialization, sales, and marketing of cannabidiol products. It operates through the following segments: Products; Testing; and Extraction and Research and Development. The Products segment focuses in the sale of cannabidiol products. The Testing segment involves in testing cannabidiol products. The Extraction and Research and Development segment include extraction and research and development operations which develops future products. The company was founded by Geremy Howard Prance Thomas on December 19, 2017 and is headquartered in London, the United Kingdom. |
Financial Conglomerates
|
Sektor
Umsatz nach Geschäftsbereich
% 1. Jan. | Kap. | |
---|---|---|
+37,08 % | 6,01 Mrd. | |
-17,43 % | 4,4 Mrd. | |
-9,46 % | 3,17 Mrd. | |
+0,51 % | 3,07 Mrd. | |
-3,53 % | 2,51 Mrd. | |
+41,15 % | 1,88 Mrd. | |
-5,15 % | 1,73 Mrd. | |
+0,09 % | 1,65 Mrd. | |
-10,38 % | 1,58 Mrd. |